معرفی
Professor Ryan Donnelly is Chair in Pharmaceutical Technology and Director of the Materials & Advanced Technologies for Healthcare (MATCH) programme at Queen's University Belfast's School of Pharmacy. His research focuses on advanced polymeric drug delivery systems, particularly microneedle technologies, with an emphasis on translational applications and patient outcomes. He leads a £3M interdisciplinary research initiative involving multiple departments, aiming to improve healthcare through innovative materials and technologies.
Education
- BSc (1st Class) in Pharmacy, Queen's University Belfast (1999)
- PhD in Pharmaceutics, Queen's University Belfast (2003)
Research Interests
Prof. Donnelly's work centers on transdermal and intradermal drug delivery systems, including microneedle arrays for vaccines, therapeutics, and photodynamic therapy. His research spans HIV treatment/prevention, nanomedicine, and tropical disease therapies. Key areas include:
- Development of bioadhesive patches and hydrogel-forming microneedles
- Industrial collaboration for drug delivery innovation
- Regulatory science for microneedle-based products
Awards & Recognition
- Controlled Release Society Young Investigator Award (2016)
- BBSRC Innovator of the Year (2013)
- Royal Pharmaceutical Society Science Award (2011)
Grants & Funding
Secured over £9M in funding from BBSRC, EPSRC, Wellcome Trust, and industry partners. Notable projects include:
- Nanoengineered microneedles for HIV treatment (EPSRC-funded)
- 3D bioprinting for pharmaceutical applications (EPSRC-funded)
Labs & Collaborations
Director of MATCH, a cross-disciplinary initiative with 55 academics. Collaborations span engineering, biological sciences, and clinical disciplines. Active in editorial roles for journals like Drug Delivery & Translational Research and Journal of Controlled Release.
